ANNUAL REPORT 06 - Bosnalijek dd

O ur own programmes take par t in total realised value of sale at local market with 83.35%.New productsThe highest growth of sale (4.68%) was accomplished with disinfectantsprogramme, as a result of Bosnalijek agreed relation towards buyers andsatisfying their basic needs for these products, although inadequateimplementation of Excise Law in BiH is a serious problem for producingthis programme, because of paying a high excise duty on basic rawmaterial(alcohol), what brings us to question whether we shall furtherkeep it in our portfolio because of negative profitability.Sale of products from our own production programmes at BiH marketinvolved 198 different products, namely 175 different presentations ofmedicines based on 85 different active ingredients, 12 disinfectants formedicinal usage and 11 disinfectants for wider consumption.With development of new products and their introducing into saleassortment, with constant harmonisation of portfolio with requirementsof modern pharmacotherapeutics, Bosnalijek ensured acontinuous growth of sale and confirms strategic orientationdirected to growth of competitiveness, satisfying needs of itscustomers and end users.Nine new medicines based on 5 active ingredients were launched tomarket in year 2006, namely:• 5 medicines based on two completely new active ingredients(clarithromycin and loratadine), and• 4 medicines based on 3 active ingredients already present inmanufacturing programme (new pharmaceutical forms and unitdoses).1009080STRUCTURE OF SALE AT LOCAL MARKET 2003 - 2007.80% 81% 83% 83%70OUR OWN PROGRAMMECOOPERATION-PARTNERSSTRUCTURE OF SALE IN BiH BY PROGRAMMES605040302010020% 19% 17% 17%2003 2004 2005 2006serving Your health BOSNIA AND HERZEGOVINA MARKET ANNUAL REPORT 06 23